Ingamells S, Campbell I G, Anthony F W, Thomas E J
Department of Obstetrics and Gynaecology, University of Southampton.
J Reprod Fertil. 1996 Jan;106(1):33-8. doi: 10.1530/jrf.0.1060033.
The human endometrium undergoes regular cyclical changes under the endocrine control of oestrogens and progesterone acting via specific nuclear receptors. The molecular and cellular events mediating these changes are not understood. The present study examined the changes in the endometrial progesterone receptor and its mRNA during the menstrual cycle. Forty-four endometrial samples obtained from women with normal menstrual cycles were divided into four categories: early proliferative (days 6-9), late proliferative (days 10-14), early secretory (days 15-21) and late secretory (days 22-28). The progesterone receptor protein was determined using a human progesterone receptor enzyme-linked immunoassay kit. Total RNA was extracted using RNAzol and the abundance of mRNA encoding the progesterone receptor was determined by reverse transcriptase-polymerase chain reaction and by northern blot analysis. The concentration of the progesterone receptor in the endometrium was highest during the late proliferative phase and was lowest in the late secretory phase. Significant differences were observed between the menstrual cycle phases (P < 0.003). No cyclical variation was observed in the concentration of mRNA encoding for the progesterone receptor in the endometrium when analysed by reverse transcriptase polymerase chain reaction or by northern analysis. There appears to be no association between the amounts of mRNA encoding the progesterone receptor and progesterone receptor protein during the menstrual cycle suggesting that the control of the expression of the progesterone receptor may not occur solely at the transcriptional level.
在雌激素和孕激素通过特定核受体发挥作用的内分泌控制下,人类子宫内膜会经历周期性变化。介导这些变化的分子和细胞事件尚不明确。本研究检测了月经周期中子宫内膜孕激素受体及其mRNA的变化。从月经周期正常的女性获取的44份子宫内膜样本被分为四类:增殖早期(第6 - 9天)、增殖晚期(第10 - 14天)、分泌早期(第15 - 21天)和分泌晚期(第22 - 28天)。使用人孕激素受体酶联免疫分析试剂盒测定孕激素受体蛋白。用RNAzol提取总RNA,并通过逆转录-聚合酶链反应和Northern印迹分析来测定编码孕激素受体的mRNA丰度。子宫内膜中孕激素受体的浓度在增殖晚期最高,在分泌晚期最低。月经周期各阶段之间观察到显著差异(P < 0.003)。当通过逆转录聚合酶链反应或Northern分析进行分析时,未观察到子宫内膜中编码孕激素受体的mRNA浓度有周期性变化。在月经周期中,编码孕激素受体的mRNA量与孕激素受体蛋白量之间似乎没有关联,这表明孕激素受体表达的调控可能并非仅发生在转录水平。